30 results
DEFR14A
6u685izfhw
12 May 22
Revised proxy
5:00pm
8-K
EX-99.1
7wast4e9
9 May 22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
4:20pm
8-K
EX-99.1
158cp scbha1hmtr
20 Apr 22
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study
5:24pm
8-K
EX-1.1
bb0 qpqpnpu
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
b8ihnq
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am